ALB and chronic kidney disease: The potential of MSC-Evs in clinical use has been also demonstrated in a previous report, in which administration of MSC-Evs improved symptom, reduced serum creatinine, and improved urinary albumin creatinine ratio without significant side-effects in patients with long-term chronic kidney disease [34].